QiC Excellence in Oncology, a programme to recognise individuals or teams involved in the support, care and treatment of cancer patients in the UK, has received over 100 entries across 12 categories in its first year.
Supported by Cancer 52, Beating Bowel Cancer, the National Cancer Action Team, and with industry partners such as Pfizer, BMS and Novartis, the programme is based upon the Pfizer Excellence in Oncology Awards, with winners to be announced on November 6 at The Hilton, Liverpool, during the National Cancer Research Institute's (NCRI) annual conference.
Following the awards ceremony, winning work will be showcased at events across the country, and will feature in QiC Connect – an online knowledge hub for healthcare practice in the UK.
Entry was open to teams or individuals working in the NHS, voluntary or commercial sectors, with joint working and collaboration key to the QiC Programmes.
Categories in the programme include Cancer Professional of the Year and Cancer Charity Initiative of the Year, as well as awards in line with the NHS Outcomes Framework, such as Patient Experience and Patient Safety.
There is also a Lifetime Achievement Award, given to an individual who has made an outstanding contribution to the field of cancer.
Commenting the high standard of entries, Rob Day, UK Oncology Business Unit Head, Pfizer, said: “This is an excellent achievement and really demonstrates the importance of and interest in the awards.”
Jenny Ritchie-Campbell, director, cancer services innovation, Macmillan Cancer Support, said: "Macmillan Cancer Support aims to support people with cancer every step of the way and push for better cancer care. We are delighted to support the Quality in Care Oncology programme which will identify and share good practice and help to spread the expertise and knowledge of successful innovations."
• Find further details about QiC Excellence in Oncology, including the full list of categories and supporters. Finalists will be announced on the QiC website in the middle of September.
QiC Excellence in Oncology runs concurrent with QiC Diabetes, a similar programme to recognise and share good healthcare practice in diabetes within the UK.